Disclosures for "Patient-reported Outcomes Through 12-weeks of Double-blind Rimegepant Treatment for the Prevention of Episodic Migraine in Adults with Prior Inadequate Response to Oral Preventatives"
-
Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome Therapeutics. Dr. Starling has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Starling has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Miller Medical. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Salvia. Dr. Starling has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eNeura. Dr. Starling has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Woodberry Associates .
-
Jan Versijpt has nothing to disclose.
-
The institution of Dr. Sumelahti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. The institution of Dr. Sumelahti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. The institution of Dr. Sumelahti has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Sumelahti has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for pfizer. Dr. Sumelahti has received publishing royalties from a publication relating to health care.
-
Dr. Aslan has received personal compensation for serving as an employee of Pfizer. Dr. Aslan has stock in Pfizer Inc.
-
Ms. Seehra has stock in Pfizer.
-
Mrs. Ramaker has received personal compensation for serving as an employee of Pfizer. Mrs. Ramaker has stock in Pfizer.
-
Ms. McCollum has received personal compensation for serving as an employee of Pfizer.
-
Dr. Thiry has received personal compensation for serving as an employee of Pfizer. Dr. Thiry has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Thiry has stock in Pfizer. Dr. Thiry has stock in Biohaven Pharmaceuticals.
-
Lucy Abraham has received personal compensation for serving as an employee of Pfizer R&D UK Ltd. Lucy Abraham has stock in Pfizer R&D UK Ltd.
-
Robert Fountaine has received personal compensation for serving as an employee of Pfizer, Inc.. Robert Fountaine has stock in Pfizer, Inc. Robert Fountaine has stock in Viatris, Inc.
-
Dr. Ramirez has received personal compensation for serving as an employee of Pfizer.